U.S. market Closed. Opens in 29 minutes

ROIVW | Roivant Sciences Ltd. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ROIVW we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is stunning wealthy, Growth is very good and Health is strong.

Valuation (28%)

Company Industry
P/E Ratio (TTM) 1,839.53 -22.70
PEG Ratio (TTM) 194.77 15.51
P/S Ratio (TTM) 121.95 49.77
P/B Ratio (TTM) 1,602.87 18.47
P/FCF Ratio (TTM) -11.87 -2.07
Price to 5YR AVG Earnings Ratio 3.46 -2.81
Price to 5YR AVG FCF Ratio -12.08 -8.72

Profitability (100%)

Company Industry
ROA (TTM) 72.90% -4.91%
ROE (TTM) 102.72% 19.63%
Net Profit Margin (TTM) 6,596.16% -1,522.48%
ROIC 5YR AVG 56.12% 15.93%

Growth (78%)

4QTR AVG 3YR AVG 5YR AVG
EPS 438.17% 31.98% 98.28%
Revenue 35.04% 960.04% 598.92%
Net Income 457.60% 12.53% 91.61%
Cash Flow -3.77% 10.13% 3.04%

Health (63%)

Company Industry
Current Ratio (TTM) 27.91 6.13
Quick Ratio (TTM) 27.91 5.85
D/E Ratio (TTM) 0.07 -16.33
Interest Coverage (TTM) 112.01 -1.36
Piotroski F-Score 4 5
Altman Z-Score 12.46 13.92
LTL to 5YR AVG FCF -0.66 0.17
Shares Outstanding Growth 5YR AVG 44.10% 129.85%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙